Literature DB >> 33500439

A clinico-pathological and molecular analysis reveals differences between solitary (early and late-onset) and synchronous rectal cancer.

José Perea1,2, Juan L García3, Luis Corchete3, Sandra Tapial4, Susana Olmedillas-López5, Alfredo Vivas6, Damián García-Olmo7,5, Miguel Urioste8,9, Ajay Goel10, Rogelio González-Sarmiento3.   

Abstract

Rectal cancer (RC) appears to behave differently compared with colon cancer. We aimed to analyze existence of different subtypes of RC depending on distinct features (age of onset and the presence of synchronous primary malignant neoplasms). We compared the clinicopathological, familial and molecular features of three different populations diagnosed with RC (early-onset RC [EORC], late-onset RC, and synchronous RC [SRC]). Eighty-five RCs were identified and were evaluated according to their microsatellite instability, CpG Island Methylator Phenotype (CIMP) and chromosomal instability, as assessed by Next Generation Sequencing and microarray-based comparative genomic hybridization approaches. The results were subjected to cluster analysis. SRCs displayed the most specific characteristics including a trend for the development of multiple malignant neoplasms, a greater proportion of CIMP-High tumors (75%) and more frequent genomic alterations. These findings were confirmed by a clustering analysis that stratified RCs according to their genomic alterations. We also found that EORCs exhibited their own features including an important familial cancer component and a remarkable rate of mutations in TP53 (53%). Together, heterogeneity in RC characteristics by age of disease-onset and SRC warrants further study to optimize tailored prevention, detection and intervention strategies-particularly among young adults.

Entities:  

Year:  2021        PMID: 33500439      PMCID: PMC7838158          DOI: 10.1038/s41598-020-79118-z

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  39 in total

1.  Synchronous colorectal cancer: not just bad luck?

Authors:  Barbara A Leggett; Daniel L Worthley
Journal:  Gastroenterology       Date:  2009-09-27       Impact factor: 22.682

2.  Toward a Molecular Classification of Synchronous Colorectal Cancer: Clinical and Molecular Characterization.

Authors:  María Arriba; Ricardo Sánchez; Daniel Rueda; Laura Gómez; Juan L García; Yolanda Rodríguez; José Antonio Pajares; Jessica Pérez; Miguel Urioste; Rogelio González Sarmiento; José Perea
Journal:  Clin Colorectal Cancer       Date:  2016-08-09       Impact factor: 4.481

3.  Global patterns and trends in colorectal cancer incidence in young adults.

Authors:  Rebecca L Siegel; Lindsey A Torre; Isabelle Soerjomataram; Richard B Hayes; Freddie Bray; Thomas K Weber; Ahmedin Jemal
Journal:  Gut       Date:  2019-09-05       Impact factor: 23.059

4.  The increasing incidence of young-onset colorectal cancer: a call to action.

Authors:  Dennis J Ahnen; Sally W Wade; Whitney F Jones; Randa Sifri; Jose Mendoza Silveiras; Jasmine Greenamyer; Stephanie Guiffre; Jennifer Axilbund; Andrew Spiegel; Y Nancy You
Journal:  Mayo Clin Proc       Date:  2014-01-04       Impact factor: 7.616

5.  The mechanism of microsatellite instability is different in synchronous and metachronous colorectal cancer.

Authors:  Fernando S Velayos; Suk-Hwan Lee; Hongming Qiu; Sharon Dykes; Raymond Yiu; Jonathan P Terdiman; Julio Garcia-Aguilar
Journal:  J Gastrointest Surg       Date:  2005-03       Impact factor: 3.452

6.  Distinct high resolution genome profiles of early onset and late onset colorectal cancer integrated with gene expression data identify candidate susceptibility loci.

Authors:  Marianne Berg; Trude H Agesen; Espen Thiis-Evensen; Marianne A Merok; Manuel R Teixeira; Morten H Vatn; Arild Nesbakken; Rolf I Skotheim; Ragnhild A Lothe
Journal:  Mol Cancer       Date:  2010-05-06       Impact factor: 27.401

7.  Age at onset should be a major criterion for subclassification of colorectal cancer.

Authors:  José Perea; Daniel Rueda; Alicia Canal; Yolanda Rodríguez; Edurne Álvaro; Irene Osorio; Cristina Alegre; Bárbara Rivera; Joaquín Martínez; Javier Benítez; Miguel Urioste
Journal:  J Mol Diagn       Date:  2013-10-30       Impact factor: 5.568

8.  Comprehensive characterization of RAS mutations in colon and rectal cancers in old and young patients.

Authors:  Ilya G Serebriiskii; Caitlin Connelly; Garrett Frampton; Justin Newberg; Matthew Cooke; Vince Miller; Siraj Ali; Jeffrey S Ross; Elizabeth Handorf; Sanjeevani Arora; Christopher Lieu; Erica A Golemis; Joshua E Meyer
Journal:  Nat Commun       Date:  2019-08-19       Impact factor: 14.919

9.  Cimp-Positive Status is More Representative in Multiple Colorectal Cancers than in Unique Primary Colorectal Cancers.

Authors:  Sandra Tapial; Susana Olmedillas-López; Daniel Rueda; María Arriba; Juan L García; Alfredo Vivas; Jessica Pérez; Laura Pena-Couso; Rocío Olivera; Yolanda Rodríguez; Mariano García-Arranz; Damián García-Olmo; Rogelio González-Sarmiento; Miguel Urioste; Ajay Goel; José Perea
Journal:  Sci Rep       Date:  2019-07-19       Impact factor: 4.379

10.  The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers.

Authors:  D A Lawes; T Pearson; S Sengupta; P B Boulos
Journal:  Br J Cancer       Date:  2005-08-22       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.